Alert

Recommended Alerts

Sign Up For Alerts

DOJ Increases Focus on Clinical Trial Fraud

While speaking at the Food & Drug Law Institute’s Enforcement, Litigation and Compliance Conference in December, Deputy Assistant Attorney General Arun Rao identified clinical trial fraud as one of four key areas of enforcement focus by the Consumer Protection Branch of the U.S. Department of Justice (“DOJ”).

Read More

FDA Publicly Releases Guidelines for Park Prosecutions Following FOIA Appeals

Practices: Government Enforcement / White Collar Criminal Defense, Life Sciences Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

Cookie Settings